Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 390

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 390
---
 exercise their warrants on a cashless basis. The
Public Warrants will expire five years after the completion of a business combination or earlier upon redemption or liquidation.

Once the warrants become exercisable, the Company
may redeem the Public Warrants:

| ● | in                     
 whole and not in part; |

| ● | at a price of $0.01 per 
 warrant;                |

| ● | upon not less than 30 days’         
 prior written notice of redemption; |

| ● | if, and only if, the reported                                                                                                               
 last sale price of Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations  
 and recapitalizations), for any 20 trading days within a 30-trading-day period commencing at any time after the warrants become exercisable 
 and ending on the third business day prior to the notice of redemption to warrant holders; and                                              |

| ● | if, and only if, there                                                                                                    
 is a current registration statement in effect with respect to the shares of Class A common stock underlying the warrants. |

If the Company calls the Public Warrants for redemption,
management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,”
as described in the warrant agreement.

The Private Placement Warrants are identical to
the Public Warrants underlying the Units sold in the IPO, except that the Private Placement Warrants and the common stock issuable upon
the exercise of the Private Placement Warrants will not be transferable, assignable, or salable until after the completion of a business
combination, subject to certain limited exceptions. The Private Placement Warrants will be redeemable by the Company and exercisable
by such holders on the same basis as the Public Warrants.

The exercise price and number of shares of common
stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary
dividend or recapitalization, reorganization, merger, or consolidation. However, the warrants will not be adjusted for issuances of common
stock at a price below their respective exercise prices, other than as set forth below. Additionally, in no event will the Company be
required to net cash settle the warrants. If the Company is unable to complete a business combination within the Combination Period and
the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect